Ice Integrated Clinical Excellence Ltd - Accounts to registrar (filleted)

REGISTERED NUMBER: 07201073 (England and Wales)

Financial Statements

for the Year Ended 31st March 2025

for

ICE INTEGRATED CLINICAL EXCELLENCE

LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs J Randall

A R Shaw

N R Watts

REGISTERED OFFICE:

15 Grove Place

Bedford

MK40 3JJ

REGISTERED NUMBER:

07201073 (England and Wales)

ACCOUNTANTS:

John Wildman Chartered Accountants

15 Grove Place

Bedford

MK40 3JJ

FIXED ASSETS

Tangible assets

4

25,098

27,498

CURRENT ASSETS

Debtors

5

40,712

37,549

Cash at bank and in hand

84,913

119,260

125,625

156,809

CREDITORS

Amounts falling due within one year

6

140,737

162,612

NET CURRENT LIABILITIES

(15,112

)

(5,803

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

9,986

21,695

CAPITAL AND RESERVES

Called up share capital

7

6

Retained earnings

8

9,980

21,689

SHAREHOLDERS' FUNDS

9,986

21,695

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1st December 2025 and were signed on its behalf by:

Mrs J Randall - Director

A R Shaw - Director

N R Watts - Director

1.	STATUTORY INFORMATION

Ice Integrated Clinical Excellence Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

These financial statements are prepared on the going concern basis as it is the intention of the directors to continue supporting the company for the foreseeable future.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Equipment & fittings

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2024 - 13 ) .

4.	TANGIBLE FIXED ASSETS

Equipment

& fittings

£

COST

At 1st April 2024

and 31st March 2025

46,298

DEPRECIATION

At 1st April 2024

18,800

Charge for year

2,400

At 31st March 2025

21,200

NET BOOK VALUE

At 31st March 2025

25,098

At 31st March 2024

27,498

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

Trade debtors

40,712

37,549

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

Bank loan - BBL

13,074

23,253

Trade creditors

36,202

35,568

Corporation tax

36,995

29,006

Pension fund creditor

-

584

Due on credit cards

1,122

3,840

Directors' current accounts

53,344

70,361

140,737

162,612

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.25

31.3.24

value:

£

2

A Ordinary

£1

2

B Ordinary

£1

2

C Ordinary

£1

2

6

8.

RESERVES

Retained

earnings

£

At 1st April 2024

21,689

Profit for the year

115,185

Dividends

(126,894

)

At 31st March 2025

9,980